Parkinson's disease

Parkinson's disease

  • April 2015 •
  • 290 pages •
  • Report ID: 4035432 •
  • Format: PDF
Population aging and the introduction of new therapies for late-stage disease will grow the mature Parkinson’s disease market

This report addresses the following questions:

- What will be the growth drivers of the Parkinson’s disease market?
- Which are the current top brands of the Parkinson’s disease market, and which new leaders will emerge after Azilect’s US patent expiry in 2017?
- What is the landscape of early- and late-stage drug development in Parkinson’s disease?
- How are Parkinson’s disease patients managed across the different disease stages?
- Which treatment challenges still remain to be addressed?
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.